Glycolysis inhibition for anticancer treatment
H Pelicano, DS Martin, P Huang - Oncogene, 2006 - nature.com
Most cancer cells exhibit increased glycolysis and use this metabolic pathway for generation
of ATP as a main source of their energy supply. This phenomenon is known as the Warburg …
of ATP as a main source of their energy supply. This phenomenon is known as the Warburg …
[PDF][PDF] Glycolysis inhibition for anticancer treatment
H Pelicano, DS Martin, RH Xu, P Huang - Oncogene, 2006 - jeffreydachmd.com
Therapeutic selectivity, or preferential killing of cancer cells without significant toxicity to
normal cells, is one of the most important considerations in cancer chemotherapy …
normal cells, is one of the most important considerations in cancer chemotherapy …
[PDF][PDF] Glycolysis inhibition for anticancer treatment
H Pelicano, DS Martin, RH Xu, P Huang - Oncogene, 2006 - academia.edu
Therapeutic selectivity, or preferential killing of cancer cells without significant toxicity to
normal cells, is one of the most important considerations in cancer chemotherapy …
normal cells, is one of the most important considerations in cancer chemotherapy …
Glycolysis inhibition for anticancer treatment
H Pelicano, DS Martin, RH Xu, P Huang - Oncogene, 2006 - pubmed.ncbi.nlm.nih.gov
Most cancer cells exhibit increased glycolysis and use this metabolic pathway for generation
of ATP as a main source of their energy supply. This phenomenon is known as the Warburg …
of ATP as a main source of their energy supply. This phenomenon is known as the Warburg …
Glycolysis inhibition for anticancer treatment.
H Pelicano, DS Martin, RH Xu, P Huang - Oncogene, 2006 - europepmc.org
Most cancer cells exhibit increased glycolysis and use this metabolic pathway for generation
of ATP as a main source of their energy supply. This phenomenon is known as the Warburg …
of ATP as a main source of their energy supply. This phenomenon is known as the Warburg …
[PDF][PDF] Glycolysis inhibition for anticancer treatment
H Pelicano, DS Martin, RH Xu… - Oncogene, 2006 - medicinacomplementar.com.br
Therapeutic selectivity, or preferential killing of cancer cells without significant toxicity to
normal cells, is one of the most important considerations in cancer chemotherapy …
normal cells, is one of the most important considerations in cancer chemotherapy …
Glycolysis inhibition for anticancer treatment
H Pelicano, DS Martin, RH Xu, P Huang - Oncogene, 2006 - go.gale.com
Most cancer cells exhibit increased glycolysis and use this metabolic pathway for generation
of ATP as a main source of their energy supply. This phenomenon is known as the Warburg …
of ATP as a main source of their energy supply. This phenomenon is known as the Warburg …
[引用][C] Glycolysis inhibition for anticancer treatment
H PELICANO, DS MARTIN, RH XU… - Oncogene …, 2006 - pascal-francis.inist.fr
Glycolysis inhibition for anticancer treatment CNRS Inist Pascal-Francis CNRS Pascal and
Francis Bibliographic Databases Simple search Advanced search Search by classification …
Francis Bibliographic Databases Simple search Advanced search Search by classification …
Glycolysis inhibition for anticancer treatment
H Pelicano, DS Martin, RH Xu… - Oncogene, 2006 - mdanderson.elsevierpure.com
Most cancer cells exhibit increased glycolysis and use this metabolic pathway for generation
of ATP as a main source of their energy supply. This phenomenon is known as the Warburg …
of ATP as a main source of their energy supply. This phenomenon is known as the Warburg …